Literature DB >> 28064358

Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series.

Koji Yoshida1, Yukiko Hata2, Koshi Kinoshita2, Shutaro Takashima1, Kortaro Tanaka1, Naoki Nishida3.   

Abstract

We investigated 998 serial Japanese forensic autopsy cases (0-101 years old, mean age 61.7 ± 21.9), with no case selection, using immunohistochemistry to detect cases with progressive supranuclear palsy (PSP). Twenty-nine cases (mean age 82.3 ± 7.2 years, 11 males, 18 females) fulfilled the National Institute of Neuronal Disorders and Stroke (NINDS)-PSP pathological criteria (2.9% of all cases, 4.6% of cases over 60). All had neuronal and glial inclusions in the basal ganglia and brainstem. However, 13 cases had low tau pathology and were categorized as atypical PSP. In addition to PSP pathology, multiple types of astrocytic inclusions and comorbid proteinopathies, particularly a high prevalence of argyrophilic grain disease, were found. All cases had not been diagnosed with PSP and had preserved daily functioning prior to death. However, 14 (48.3%), 11 (37.9%), and 16 (55.2%) cases showed signs of dementia, depressive state, and gait disturbance, respectively. Sixteen accidental death cases (55.2%), including from falls and getting lost, and 11 suicide cases (37.9%) appear to have a relationship with incipient PSP pathology. Cluster analysis using the distribution and amount of 4-repeat-tau pathology classified the cases into three subgroups: Group 1 (10 cases) had typical PSP pathology and seven cases (70.0%) had dementia as the most frequent symptom; Group 2 (7 cases) had significantly higher frequency of gait disorder (6 cases, 85.7%), and less neocortical tau pathology than Group 1; Group 3 (12 cases) had relatively mild PSP pathology and high argyrophilic grain burdens. Granular-shaped astrocytes were the dominant astrocytic inclusion in all cases. We conclude that in forensic cases incipient PSP occurs with a higher prevalence than expected. If these findings can be extrapolated to other population-based cohorts, PSP may be more common than previously thought.

Entities:  

Keywords:  Astrocytes; Autopsy; Immunohistochemistry; Neuropathology; Progressive supranuclear palsy; Tauopathy

Mesh:

Substances:

Year:  2017        PMID: 28064358     DOI: 10.1007/s00401-016-1665-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

Review 1.  Protein astrogliopathies in human neurodegenerative diseases and aging.

Authors:  Gabor G Kovacs; Virginia M Lee; John Q Trojanowski
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

Review 2.  Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

Authors:  Adam L Boxer; Jin-Tai Yu; Lawrence I Golbe; Irene Litvan; Anthony E Lang; Günter U Höglinger
Journal:  Lancet Neurol       Date:  2017-06-13       Impact factor: 44.182

Review 3.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

4.  Alzheimer's Disease Neuropathological Comorbidities are Common in the Younger-Old.

Authors:  Thomas G Beach; Michael Malek-Ahmadi
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

5.  Distribution patterns of tau pathology in progressive supranuclear palsy.

Authors:  Gabor G Kovacs; Milica Jecmenica Lukic; David J Irwin; Thomas Arzberger; Gesine Respondek; Edward B Lee; David Coughlin; Armin Giese; Murray Grossman; Carolin Kurz; Corey T McMillan; Ellen Gelpi; Yaroslau Compta; John C van Swieten; Laura Donker Laat; Claire Troakes; Safa Al-Sarraj; John L Robinson; Sigrun Roeber; Sharon X Xie; Virginia M-Y Lee; John Q Trojanowski; Günter U Höglinger
Journal:  Acta Neuropathol       Date:  2020-05-07       Impact factor: 17.088

Review 6.  Frontrunner in Translation: Progressive Supranuclear Palsy.

Authors:  Ali Shoeibi; Nahid Olfati; Irene Litvan
Journal:  Front Neurol       Date:  2019-10-22       Impact factor: 4.003

7.  Assisted Suicide in Parkinsonian Disorders.

Authors:  Georg S Nuebling; Elisabeth Butzhammer; Stefan Lorenzl
Journal:  Front Neurol       Date:  2021-03-15       Impact factor: 4.003

8.  Neuropathology of SCA34 showing widespread oligodendroglial pathology with vacuolar white matter degeneration: a case study.

Authors:  Kokoro Ozaki; Takashi Irioka; Toshiki Uchihara; Akane Yamada; Ayako Nakamura; Takamasa Majima; Susumu Igarashi; Hiroshi Shintaku; Mayumi Yakeishi; Yukio Tsuura; Yasushi Okazaki; Kinya Ishikawa; Takanori Yokota
Journal:  Acta Neuropathol Commun       Date:  2021-10-24       Impact factor: 7.801

9.  Is the Phenotype Designation by PSP-MDS Criteria Stable Throughout the Disease Course and Consistent With Tau Distribution?

Authors:  Javier Sánchez-Ruiz de Gordoa; Victoria Zelaya; Paula Tellechea-Aramburo; Blanca Acha; Miren Roldán; Carlos López-Molina; Valle Coca; Arkaitz Galbete; Maite Mendioroz; M Elena Erro
Journal:  Front Neurol       Date:  2022-02-03       Impact factor: 4.003

10.  Factors associated with development and distribution of granular/fuzzy astrocytes in neurodegenerative diseases.

Authors:  Tomoko Miki; Osamu Yokota; Takashi Haraguchi; Hideki Ishizu; Masato Hasegawa; Takeshi Ishihara; Shu-Ichi Ueno; Shintaro Takenoshita; Seishi Terada; Norihito Yamada
Journal:  Brain Pathol       Date:  2020-05-06       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.